Clinical Trials Browser

Phase 3 × Not yet recruiting × 130-nm albumin-bound paclitaxel × Clear all

NCT07436741 2026-02-27

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

Phase 3 Not yet recruiting

Gastrointestinal

Pancreatic cancer, adult

NCT07272109 2025-12-15

PTCA199-16

Phase 3 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07155629 2025-09-04

LEFT-PANC

Phase 3 Not yet recruiting

Gastrointestinal

Pancreatic Cancer Resectable

NCT04301739 2020-03-12

to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC)

Phase 3 Not yet recruiting

Triple Negative Breast Neoplasms